AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2014
Sep 23, 2014
32566_dirs_2014-09-23_fb916d90-e12f-4161-b630-65e3372e4f94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-09-19
Reporting Person: Evans James S (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-19 | Common Stock | M | 1.0 | $16.53 | Acquired | 48129 | Direct |
| 2014-09-19 | Common Stock | S | 1.0 | $37.337 | Disposed | 48128 | Direct |
| 2014-09-19 | Common Stock | M | 4328.0 | $23.11 | Acquired | 52456 | Direct |
| 2014-09-19 | Common Stock | S | 4328.0 | $37.337 | Disposed | 48128 | Direct |
| 2014-09-19 | Common Stock | M | 2346.0 | $30.12 | Acquired | 50474 | Direct |
| 2014-09-19 | Common Stock | S | 2346.0 | $37.51 | Disposed | 48128 | Direct |
| 2014-09-19 | Common Stock | M | 5324.0 | $13.28 | Acquired | 53452 | Direct |
| 2014-09-19 | Common Stock | S | 5324.0 | $37.337 | Disposed | 48128 | Direct |
| 2014-09-19 | Common Stock | M | 5808.0 | $12.17 | Acquired | 53936 | Direct |
| 2014-09-19 | Common Stock | S | 5808.0 | $37.337 | Disposed | 48128 | Direct |
| 2014-09-19 | Common Stock | M | 664.0 | $9.04 | Acquired | 48792 | Direct |
| 2014-09-19 | Common Stock | S | 664.0 | $37.51 | Disposed | 48128 | Direct |
| 2014-09-19 | Common Stock | M | 13128.0 | $8.63 | Acquired | 61256 | Direct |
| 2014-09-19 | Common Stock | S | 13128.0 | $37.51 | Disposed | 48128 | Direct |
| 2014-09-22 | Common Stock | M | 3000.0 | $30.12 | Acquired | 51128 | Direct |
| 2014-09-22 | Common Stock | S | 3000.0 | $37.98 | Disposed | 48128 | Direct |
| 2014-09-23 | Common Stock | M | 75864.0 | $30.12 | Acquired | 123992 | Direct |
| 2014-09-23 | Common Stock | S | 75864.0 | $38.0826 | Disposed | 48128 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-19 | Incentive Stock Option (right to buy) | $8.63 | M | 13128.0 | Disposed | 2016-02-16 | Common Stock (13128) | Direct |
| 2014-09-19 | Incentive Stock Option (right to buy) | $9.04 | M | 664.0 | Disposed | 2016-09-06 | Common Stock (664) | Direct |
| 2014-09-19 | Incentive Stock Option (right to buy) | $12.17 | M | 5808.0 | Disposed | 2017-02-21 | Common Stock (5808) | Direct |
| 2014-09-19 | Incentive Stock Option (right to buy) | $13.28 | M | 5324.0 | Disposed | 2018-02-28 | Common Stock (5324) | Direct |
| 2014-09-19 | Incentive Stock Option (right to buy) | $16.53 | M | 1.0 | Disposed | 2020-09-15 | Common Stock (1) | Direct |
| 2014-09-19 | Incentive Stock Option (right to buy) | $23.11 | M | 4328.0 | Disposed | 2020-03-03 | Common Stock (4328) | Direct |
| 2014-09-19 | Incentive Stock Option (right to buy) | $30.12 | M | 2346.0 | Disposed | 2019-02-18 | Common Stock (2346) | Direct |
| 2014-09-22 | Non-Qualified Stock Option (right to buy) | $30.12 | M | 3000.0 | Disposed | 2019-02-18 | Common Stock (3000) | Direct |
| 2014-09-23 | Non-Qualified Stock Option (right to buy) | $30.12 | M | 75864.0 | Disposed | 2019-02-18 | Common Stock (75864) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2